CDRD Appoints Wendy Hurlburt & William Charnetski to its Board of Directors
Vancouver, Canada: CDRD, Canada’s national life sciences venture, is pleased to announce the appointments of Ms. Wendy Hurlburt and Mr. William Charnetski as new Directors of the organization.
Wendy Hurlburt, an executive with more than 20 years of global finance, operations and compliance experience in the healthcare and technology sectors, has held leadership positions in Johnson & Johnson, the Heart and Stroke Foundation, and Lexmark International. In these organizations, she provided strategic leadership across Finance, Operations, IT, Privacy, Compliance, Regulatory, Quality and Risk Management, with her global experience spanning Canada, the United States, Europe and South Asia.
Ms. Hurlburt has an extensive history of successfully parlaying her strong business acumen into the leading of global strategic partnerships, new business development initiatives, transformation projects, and the integration of new businesses and/or business models. The result has been a proven track record of developing, executing, and delivering solid business plans, and growing revenues and shareholder value.
William Charnetski is an accomplished national and global executive who has worked in the highest levels of business, law and government; most recently as the Chief Health Innovation Strategist for the province of Ontario. He has a track record of leading transformational change, developing organizations, leading people to realize their potential, fostering internal and external partnerships and collaboration, and delivering results. He has spent more than 15 years working on integrated health solutions in Canada and around the world in the rapidly changing global pharmaceutical and broader health industries.
Prior to his role with the province of Ontario, Mr. Charnetski worked in the United Kingdom with AstraZeneca, where he led the global government affairs and public policy function and had responsibilities for corporate social responsibility and regional communications. His team delivered tangible business results while enhancing health outcomes in many places around the world. His work across the Canadian health care system has included building collaborative approaches to adopting innovative value-adding technologies across a variety of fields of study. In particular, he was an original member of the Advisory Council of the Ivey International Centre for Health Innovation at Western University and the Steering Committee of the Centre for the Advancement of Health Innovation (within the Conference Board of Canada), and a member of the Board of Directors of the Institute of Health Economics in Edmonton.
CDRD Board Chair, Dr. Brad Popovich commented, “On behalf of the CDRD Board of Directors, I am pleased to welcome these two outstanding life sciences leaders who have made tremendous contributions to our sector. They bring experience from around the world to our table and will be great assets as CDRD implements its new strategies based on the venture partner model.”
Mr. Gordon C. McCauley, President and CEO of CDRD added, “The CDRD leadership team is very much looking forward to working with Wendy and Bill. Their experienced voices will prove invaluable as we set the course for the future of CDRD, and continue to work with our partners in order to fully realize our vision of Canadian life sciences leading the world.
– 30 –
CDRD is Canada’s national life sciences venture, powering the country’s life sciences industry by creating and growing companies of scale – while training the scientific and business talent needed to drive them to become leading global anchors for Canada. We do this by building collaborations with the very best partners from academia, industry, patient foundations, the investment community, and other Key Opinion Leaders , and providing the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector — and ultimately into new therapies for patients. www.cdrd.ca
For additional Information, please contact:
Senior Manager, Communications, CDRD
604.827.1226 / email@example.com